Spots Global Cancer Trial Database for tuberous sclerosis complex (tsc)
Every month we try and update this database with for tuberous sclerosis complex (tsc) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | NCT00790400 | Tuberous Sclero... Lymphangioleiom... | Everolimus (RAD... Everolimus Plac... | 18 Years - | Novartis | |
| Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex | NCT00411619 | Tuberous Sclero... Subependymal Gi... | Everolimus | 3 Years - | Children's Hospital Medical Center, Cincinnati | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Topical Everolimus in Patients With Tuberous Sclerosis Complex | NCT02860494 | Facial Angiofib... | Everolimus Placebo | 0 Years - 2 Years | Hospices Civils de Lyon | |
| Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC) | NCT03326765 | Sleep Disorder | Questionnaires electroencephal... polysomnography Actigraphy | 1 Day - 70 Years | Universitair Ziekenhuis Brussel | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) | NCT00792766 | Tuberous Sclero... Angiolipoma | everolimus (RAD... | 18 Years - 65 Years | Children's Hospital Medical Center, Cincinnati | |
| Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex | NCT00411619 | Tuberous Sclero... Subependymal Gi... | Everolimus | 3 Years - | Children's Hospital Medical Center, Cincinnati | |
| Safety of Simvastatin in LAM and TSC | NCT02061397 | Lymphangioleiom... Tuberous Sclero... | Simvastatin Sirolimus Oral ... Everolimus Oral... | 18 Years - | University of Pennsylvania | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Rapalogues for Autism Phenotype in TSC: A Feasibility Study | NCT01929642 | Tuberous Sclero... Self-injury Autism | Sirolimus Everolimus | 2 Years - 30 Years | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
